Followers | 828 |
Posts | 119591 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Monday, November 21, 2005 3:44:33 PM
1. MRX has the best dermal filler (Restylane), although other companies are working on bona fide competitors. However, IMDC’s collagen fillers are losing share because they don’t measure up.
2. MNT has a better botulinum toxin than IMDC’s Reloxin, but it is a few years behind in development. AGN’s Botox is better than Reloxin, but MNT’s toxin may be even better than Botox.
3. Whatever ensues with these four companies, the one combination that can’t happen is MNT and IMDC, who between them control the breast-implant market and are arch-enemies.
--
My prediction, FWIW: AGN acquires IMDC and then tries to undermine Reloxin by selling it to the weakest company that shows an interest.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent MRX News
- Marex Group plc Announces Pricing of Initial Public Offering • GlobeNewswire Inc. • 04/25/2024 01:33:37 AM
- Marex Group plc Announces Launch of Initial Public Offering • GlobeNewswire Inc. • 04/15/2024 01:19:28 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM